Phase II study of mFOLFIRINOX efficacy as first and subsequent lines of advanced gastrointestinal neuroendocrine tumors G3 and neuroendocrine carcinomas therapy. Phase 1b portion of the ACTION-1 phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback